Alixia

Targeting the Tumor Ecosystem to address cancer drug resistance.

Based based in San Francisco, CA, USA, Alixia works in healthcare.

Profile

Our compounds disrupt the metabolic and
inflammatory triggers in both cancer and quasi-cancerous
cells in the tumor microenvironment. By impacting multiple cell
types, we are enabling effective, lasting cancer treatments.

Alixia is positioned in healthcare, a segment that rewards a clear, focused offering.

Its base of operations is San Francisco, CA, USA.

The company is listed at the Winter 2022 stage of development.

The company reports a headcount in the 2 range.

Website: www.alixia.com